The nanotechnology industry is a fast-growing sector whith a huge potential for novel applications and astonishing profits. Like it happened with biotechnology, nanotechnology is facing a difiicult moment due to the current turmoil and the doubts raised from those calling for a moratorium in research activities as long as the potentially adverse effects are not fully ascertained.
The book starts with a thorough introduction to nanotechnology and nanomedicine and their funding sources. Once identified the contours of the subject matter, a scrutiny of the legislation currently applicable to nanotechnology and nanomedicine is carried out together with the examination of the intellectual property rights that can be envisaged to protect and valorise said innovations. The use of patents and other viable routes are considered, together with the current valuation methods, which show how a quantitative valuation in this field is not conceivable. The study takes into due consideration the monetization of innovations through ordinary, and nonconventional solutions like ad hoc initiatives, auctions, and brokerage.
Managers, IP practitioners, and scientists who deal with inventions that will be commercialized